MP06-01 NON-MUSCLE INVASIVE BLADDER CANCER SUBTYPES WITH DIFFERENTIAL RESPONSE TO INTRAVESICAL BACILLUS CALMETTE-GUERIN TREATMENT
Florus C. de Jong(Erasmus MC Cancer Institute), Tahlita C.M. Zuiverloon(Erasmus MC), Angelique C.J. van der Made, Sébastien Rinaldetti(Heidelberg University), Kimberley R. Jordan, James C. Costello(University of Colorado Cancer Center), Robert F. Hoedemaeker(PathoFinder (Netherlands)), Deric K. E. van der Schoot(Amphia Ziekenhuis), Teemu D. Laajala(University of Turku), Tokameh Mahmoudi(Erasmus MC), Joost L. Boormans(Erasmus MC), Bart Nieuwkamer(Reinier de Graaf Hospital), Egbert R. Boevé(Hôpitaux Universitaires Henri-Mondor), Emiel AM Janssen, Dan Theodorescu(University of Arizona)
Cited by 1
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|798
Advances in bladder cancer biology and therapy
|Nature reviews. Cancer|2020|783